Vambutas A, DeVoti J, Pinn W, Steinberg B M, Bonagura V R
Department of Otolaryngology, The Long Island Campus for the Albert Einstein College of Medicine, New Hyde Park, New York 11040, USA.
Clin Immunol. 2001 Oct;101(1):94-9. doi: 10.1006/clim.2001.5094.
Human papillomaviruses (HPVs) cause benign and malignant epithelial tumors of the respiratory and genital mucosa. We previously reported that recurrent respiratory papillomas caused by HPV 6/11 express low levels of antibody-detectable TAP-1, the protein that transports peptides into the endoplasmic reticulum for assembly and presentation by MHC Class I, and that the extent of TAP-1 immunostaining is inversely related to the frequency of disease recurrence. We have now determined a mechanism for the reduction in TAP-1 detection. Anti-TAP-1 antibody immunoprecipitated very low amounts of protein from papilloma cells. However, immunoprecipitation of calreticulin, another member of the MHC I assembly complex, coprecipitated TAP-1 at levels comparable to those of uninfected cells. Immunoprecipitation of an HPV-positive cell line with either anti-TAP-1 or anti-calreticulin coprecipitated HPV E7 protein. Finally, purified HPV 11 E7 protein inhibited ATP-dependent peptide transport in vitro. We propose that the interaction of E7 with TAP-1 prevents TAP-1 antibody detection and efficient peptide transport, resulting in poor presentation of viral antigen on HPV-infected cells and thus failure to mount an effective immune-mediated prevention of disease recurrence.
人乳头瘤病毒(HPV)可引发呼吸道和生殖黏膜的良性及恶性上皮肿瘤。我们之前报道过,由HPV 6/11引起的复发性呼吸道乳头瘤表达低水平的可被抗体检测到的TAP-1,TAP-1是一种将肽转运至内质网以便由MHC I类分子进行组装和呈递的蛋白质,并且TAP-1免疫染色的程度与疾病复发频率呈负相关。我们现在确定了TAP-1检测减少的一种机制。抗TAP-1抗体从乳头瘤细胞中免疫沉淀出的蛋白量极少。然而,MHC I组装复合体的另一个成员钙网蛋白的免疫沉淀共沉淀出的TAP-1水平与未感染细胞相当。用抗TAP-1或抗钙网蛋白对HPV阳性细胞系进行免疫沉淀可共沉淀出HPV E7蛋白。最后,纯化的HPV 11 E7蛋白在体外抑制ATP依赖的肽转运。我们提出,E7与TAP-1的相互作用会阻止TAP-1抗体检测及有效的肽转运,导致HPV感染细胞上病毒抗原的呈递不佳,从而无法产生有效的免疫介导以预防疾病复发。